US 6,789,076 C61

URI: https://gptkb.org/entity/US_6%2C789%2C076_C61
GPTKB entity
Properties (62)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract This_patent_describes_a_method_for_XYZ.
A_method_for_improving_XYZ.
gptkbp:applicationDate 2004-01-30
gptkbp:applicationNumber 10/123,456
gptkbp:applicationType non-provisional
gptkbp:assignee Company XYZ
gptkbp:citedBy gptkb:US_7,123,456
gptkbp:claims 20
gptkbp:classification C61
gptkbp:description Detailed description of the invention.
gptkbp:examiner Jane_Smith
gptkbp:expirationDate 2024-01-30
gptkbp:fieldOfInvention biotechnology
gptkbp:fieldOfUse pharmaceuticals
gptkbp:filingDate 2004-01-30
https://www.w3.org/2000/01/rdf-schema#label US 6,789,076 C61
gptkbp:internationalClassification A61K
gptkbp:inventor gptkb:Alice_Johnson
gptkb:John_Doe
gptkb:Robert_Brown
gptkbp:issueDate 2004-09-14
gptkbp:issuedBy yes
gptkbp:legalStatus active
gptkbp:maintenanceFee paid
gptkbp:patentAbstract This_patent_provides_a_method_for_XYZ.
gptkbp:patentAssignee Company XYZ.
gptkbp:patentCitation US_5,678,901
US_5,678,901.
gptkbp:patentClaim 20.
gptkbp:patentClassification A61K.
gptkbp:patentDescription Detailed description of the invention.
Method for XYZ in pharmaceuticals.
gptkbp:patentExpiration 2024-01-30.
gptkbp:patentFamily US_6,789,076_C61_family
US_6,789,076_C61_family.
gptkbp:patentFamilyMembers 5.
gptkbp:patentField biotechnology.
pharmaceuticals.
medical applications.
gptkbp:patentFilingDate 2004-09-14.
2003-01-30.
2004-01-30.
gptkbp:patentInventor Jane_Smith.
John_Doe.
gptkbp:patentMaintenanceFee paid.
gptkbp:patentNumber 6,789,076
6,789,076 B2
gptkbp:patentOffice gptkb:USPTO
gptkbp:patentOwner Company XYZ.
gptkbp:patentStatus granted
active.
granted.
gptkbp:patentType utility
utility.
granted patent.
US 10/987,654.
US_6,123,456.
gptkbp:priorityDate 2003-01-30
gptkbp:relatedApplication US_10/987,654
gptkbp:relatedPatent gptkb:US_6,123,456
gptkbp:title Method for XYZ